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Summary statement: 
How macromolecular complexes reach the nuclear pores is incompletely known. We 
show that the cytoplasmic peri-nuclear ecology is tuned by CRM1 to control virus 
transport to the nuclear pore complex. 
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Abstract 
Transport of large cargo through the cytoplasm requires motor proteins and 
polarized filaments. Viruses that replicate in the nucleus of post-mitotic cells use 
microtubules and the dynein/dynactin motor to traffic to the nuclear membrane, and 
deliver their genome through nuclear pore complexes (NPCs) into the nucleus. How 
virus particles (virions) or cellular cargo are transferred from microtubules to the 
NPC is unknown. Here, we analyzed trafficking of incoming cytoplasmic 
adenoviruses by single particle tracking and super-resolution microscopy. We 
provide evidence for a regulatory role of CRM1/XPO1 (chromosome-region-
maintenance-1, exportin-1) in juxta-nuclear microtubule-dependent adenovirus 
transport. Leptomycin B (LMB) abolishes nuclear targeting of adenovirus. It binds to 
CRM1, precludes CRM1-cargo binding and blocks signal-dependent nuclear export. 
LMB-inhibited CRM1 did not compete with adenovirus for binding to the nucleoporin 
Nup214 at the NPC. Instead, CRM1 inhibition selectively enhanced virion 
association with microtubules, and boosted virion motions on microtubules less than 
about two micrometers from the nuclear membrane. The data show that the nucleus 
provides positional information for incoming virions to detach from microtubules, 
engage a slower microtubule-independent motility to the NPC and enhance 
infection.   
 
  
	   3 
Introduction 
The eukaryotic cytoplasm is a complex aqueous mixture of proteins, nucleic acids, 
solutes, and a range of membrane-limited organelles and membrane-free liquid-
unmixed entities, such as stress granules, P-bodies, or the pericentriolar matrix 
(Hyman et al., 2014; Mellman and Warren, 2000; Verkman, 2002). Efficient 
navigation of cargo, for example particles larger than 500 kDa requires actin and 
microtubule filaments, and frequently the assistance of molecular motors stepping 
on the filaments in a polarized manner. Virus particles (virions) are larger than 20 
nm in diameter, and require assistance for cytoplasmic motility to cause infection 
(Dodding and Way, 2011; Greber and Way, 2006; Radtke et al., 2006). Infection 
involves motors that directly bind to virions, or move virions in endocytic or secretory 
vesicles (Greber and Way, 2006; Marsh and Helenius, 2006; Yamauchi and Greber, 
2016). While short range transport of virions often depends on actin and myosin 
motors (Taylor et al., 2011), long range cytoplasmic transport requires microtubules, 
and in case of incoming virions the minus-end directed motor complex dynein-
dynactin (Dodding and Way, 2011; Hsieh et al., 2010).  
Like cellular cargo, viruses engage in bidirectional motor-dependent motility by 
recruiting cytoskeletal motors of opposite directionality (Greber and Way, 2006; 
Scherer and Vallee, 2011; Welte, 2004). The net transport balance of a cargo is 
determined at the level of motor recruitment, motor coordination, tug-of-war between 
motors of opposite polarity, and also by post-translational modifications and 
dynamics of the microtubule tracks (Gross, 2004; Janke, 2014; Verhey and Gaertig, 
2007). For example, low concentrations of tubulin-binding compounds stabilize 
microtubules, boost the nuclear accumulation and transcriptional activity of the 
tumor suppressor p53, and also enhance the rate of movement of fluorescent 
adenovirus to the nucleus (Giannakakou et al., 2002).  
Adenovirus predominantly infects epithelial cells of the respiratory and 
gastrointestinal tracts, and conjunctiva (Robinson et al., 2013). The species C 
human adenoviruses (HAdV-C2 and C5) are wide spread, persist in adenoid tissue, 
and are life-threatening to immune-compromised individuals (Lion, 2014). They 
enter epithelial cells by receptor-mediated endocytosis (Meier et al., 2002; Wolfrum 
and Greber, 2013), disrupt the endosomal membrane, and escape as membrane-
free particles into the cytosol (Luisoni et al., 2015; Moyer et al., 2011). The transport 
of adenovirus towards the microtubule-organizing center (MTOC, often located near 
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the nucleus) depends on the dynein/dynactin motor complex (Bremner et al., 2009; 
Engelke et al., 2011; Kelkar et al., 2006; Kelkar et al., 2004; Leopold et al., 2000; 
Suomalainen et al., 1999). It is enhanced by cell signaling, such as p38/MAPK and 
protein kinase A (PKA) pathways, which are activated by incoming virions (Wolfrum 
and Greber, 2013), together with the ERK/MAPK pathway (Bruder and Kovesdi, 
1997).  
Remarkably, the direction of virion transport depends on the molecular composition 
of the particle. The incoming virion sheds accessory proteins in a stepwise manner 
during entry (Greber et al., 1993; Nakano et al., 2000). The cytosolic particles are 
leaky containers comprised of the hexon protein and viral DNA, but lacking the 
pentons and some stabilizing proteins (Luisoni et al., 2015; Puntener et al., 2011; 
Wang et al., 2013). They are different from intact virions, which are regular 
icosahedral T=25 particles of about 90 nm in diameter (Liu et al., 2010; Reddy et al., 
2010). When intact virions are experimentally delivered into the cytosol by needle-
based microinjection, they are not transported to the nucleus, but towards the cell 
periphery, mimicking nonlytic virus egress from the infected cell (Suomalainen et al., 
2001; Tollefson et al., 1996). This suggests that structural alterations in the virus 
particles and signalling induced by the incoming particles enable virion transport to 
the nuclear membrane. Besides activation of the MAPK and PKA pathways, 
incoming adenovirus activates the Rac1 pathway, and thereby triggers viral 
endocytosis and macropinocytosis of fluids (Amstutz et al., 2008; Meier et al., 2002). 
Rac1 activation by incoming adenovirus leads to stabilization of microtubule 
dynamics, and outgrowth of microtubules to the lamellar regions of cells, and 
enhances microtubule capture of cytosolic virions (Warren and Cassimeris, 2007; 
Warren et al., 2006).  
It has remained elusive precisely how adenovirus reaches the nuclear pore complex 
(NPC), where it delivers its genome into the nucleus, notably after minutes of 
docking at the NPC (Berk, 2007; Cassany et al., 2014; Strunze et al., 2011; Trotman 
et al., 2001). Intriguingly, the nuclear export factor CRM1 (chromosome region 
maintenance 1) also known as Exportin1 (Xpo1) has been implicated as a key 
player in adenovirus nuclear targeting (Smith et al., 2008; Strunze et al., 2005). 
CRM1 shuttles a large range of substrates bearing nuclear export sequences (NES) 
from the nucleus to the cytoplasm, in association with the small GTP-binding protein 
Ran (Hutten and Kehlenbach, 2007; Kirli et al., 2015; Xu et al., 2015). Following 
treatment of cells with leptomycin B (LMB), which covalently binds to a cysteine 
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residue in the central region of CRM1, and blocks the binding of NES-bearing cargo 
to CRM1 (Engelsma et al., 2004; Kudo et al., 1999; Neville and Rosbash, 1999; Sun 
et al., 2013), adenovirus no longer docks to the NPC. Yet, depending on the cell 
type, it is either arrested at the MTOC, or dispersed in the distal cytoplasm. The 
latter phenotype is observed for example in HeLa cells, which are distinct in their 
microtubule distribution (Li et al., 2012; Strunze et al., 2005; Wang et al., 2013). 
LMB precludes the uncoating and the delivery of viral DNA into the nucleus, and 
blocks infection. Here, we used machine learning-based computer vision analysis to 
map the microtubule-dependent motions of adenovirus in the perinuclear region with 
high spatio-temporal resolution, and reveal a surprising function of nuclear export in 
regulating virion transport.  
 
Results 
LMB-resistant CRM1 rescues nuclear targeting of adenovirus and 
restores infection in LMB-treated cells 
CRM1/Xpo1 is the major export factor for leucine-rich NES-bearing proteins, and 
binds in a Ran-GTP dependent manner to two cytoplasmic nucleoporins, Nup214 
and Nup358 (Engelsma et al., 2004; Fornerod et al., 1997b; Hutten and 
Kehlenbach, 2006). Nup214 and Nup358 are required for adenovirus docking and 
uncoating at the NPC, respectively (Strunze et al., 2011; Trotman et al., 2001). LMB 
inactivates human CRM1 by covalent binding to cysteine 528 (C528) located in the 
NES-binding grove of CRM1. We first tested if LMB-inhibited CRM1 interfered with 
adenovirus docking to the NPC in presence of LMB. The expression of the LMB-
resistant CRM1-C528S-mCherry mutant (expressed as a CRM1-mCherry fusion 
protein, Hilliard et al., 2010) restored the cytoplasmic localization of the endogenous 
NES-substrate Rio2 (atypical protein kinase right open reading frame 2, Zemp et al., 
2009) in LMB-treated human embryonic retinoblast (HER)-911 cells (Fig. 1A,B). 
Expression of CRM1-C528S-mCherry gave rise to infection as measured by the 
expression of transgenic GFP from a replication-defective HAdV-C5 vector (Fig. 
1A,B and Fig. S1). This was in stark contrast to non-transfected cells, or cells 
expressing CRM1-mCherry wild type (wt), which retained Rio2 in the nucleus upon 
LMB-treatment, and were resistant to infection. Infection, virion nuclear targeting 
and Rio2 nuclear export analyses in HeLa and HER-911 cells gave similar results 
(Fig. S1A-F). The subcellular distribution of incoming adenovirus particles was 
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assessed by fluorescent HAdV-C2-Atto647. The majority of the virions (> 60%) 
localized to the nucleus of control cells 90 min post infection (pi) (Fig. 1C,D). In 
LMB-treated cells expressing wt-CRM1-mCherry, the virions accumulated largely at 
the MTOC, as indicated by pericentrin staining (Fig. S1G). The expression of CRM1-
C528S-mCherry precluded virion accumulation at the MTOC, and significantly 
restored the nuclear localization of HAdV-C2-Atto647 (p=0.0041, Fig. 1C,D). A 
similar experiment with HAdV-C2-Atto488 in HeLa cells gave equivalent results, that 
is, a strong increase of virions targeted to the nucleus in LMB-treated cells 
expressing CRM1-C528S-mCherry compared to wt-CRM1-mCherry cells (p<0.0001, 
Fig. S1C,D). Together, these results show that the LMB-bound CRM1 does not 
block virion docking sites at the NPC. This result was informative, since CRM1 and 
adenovirus use Nup214 as a docking site at the NPC (Cassany et al., 2014; 
Fornerod et al., 1997a; Trotman et al., 2001). The data imply that functional CRM1 
is required for the nuclear targeting of adenovirus 
 
Inhibition of CRM1 increases microtubule-dependent motility of 
adenovirus 
We examined if CRM1 inhibition affected the cytoplasmic transport of adenovirus. 
For live cell imaging, we used ultra-flat monkey kidney TC7 cells, and monitored the 
motions of fluorescently labeled HAdV-C2-Atto488. TC7 cells are productively 
infected by species C adenoviruses in the absence of LMB, but in the presence of 
LMB, these cells accumulate incoming virions at the MTOC, akin to HER-911 cells 
(Staufenbiel et al., 1986; Strunze et al., 2005; Suomalainen et al., 1999). Virion 
motility in TC7 cells was determined by spinning disc confocal microscopy in the 
time window 30-90 min pi. Cytosolic virions are the predominant entity in this time 
window, as indicated by previous studies showing that the half time for virion 
penetration from endosomes is 15 min, and virions predominantly dock at the NPC 
after 30 min of infection (Engelke et al., 2011; Gastaldelli et al., 2008; Greber et al., 
1997; Greber and Way, 2006; Greber et al., 1993; Imelli et al., 2009; Meier et al., 
2002; Suomalainen et al., 2013; Suomalainen et al., 2001; Trotman et al., 2001). 
Movies with a length of 200 seconds were recorded at an image acquisition rate of 
25 Hz. Virion trajectories were generated by single particle tracking (Fig. 2A), and 
further analyzed by machine learning and motion segmentation (Helmuth et al., 
2007; Sbalzarini and Koumoutsakos, 2005). The location of the nucleus was 
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determined by staining live cells with the fluorophore DRAQ5, and imaging along 
with virions (Fig. 2A, grey). For the assessment of cytoplasmic virion motility, the 
boundary of the nucleus was determined by image thresholding of the DRAQ5 
nuclear signal (Fig. 2A, shown by a red line). The DRAQ5 thresholding is accurate, 
as indicated by a nearly perfect overlap of the nuclear border with POM121-GFP3, a 
marker of NPCs and the nuclear envelope (Fig. S2A, see Daigle et al., 2001). We 
conclude that DRAQ5 can be used to accurately determine the location of the 
nuclear envelope in live cells, here referred to as the ‘nuclear rim’. DRAQ5-stained 
nuclei hence serve as a reference site for the classification of subcellular virus 
motility.  
We next validated the detection of virions by conducting a nuclear targeting assay in 
live cells. Results show that LMB treatment of TC7 cells reduced the number of 
virions in the nuclear rim (Fig. 2B), in agreement with earlier results from chemically 
fixed HER-911 cells (shown in Fig. 1, and Strunze et al., 2005). Similar results were 
obtained with live cell imaging of HeLa cells, and revealed a strong increase in 
nuclear envelope targeting of virions from 0-30 min pi to 30-90 min pi (Fig. S2A-C). 
The increase of virions in very close proximity to the nuclear periphery was strongly 
blunted by LMB, indicating that the subcellular detection of virions by live cell 
imaging is reliable and accurate (Fig. S2D).  
We further characterized the virion motions by the diffusion rate, speed, run length, 
duration, and the moment scaling spectrum (MSS) slope of the trajectory elements. 
The MSS slope is a descriptor of the diffusive behavior, similar to the alpha 
coefficient of a mean square displacement plot (Ewers et al., 2005; Helmuth et al., 
2007). MSS values below 0.5 indicate confined diffusion, values of 0.5 random 
walks, and values above 0.5 diffusion with underlying drifts. Large data sets of 
several thousand trajectories for each condition showed that the overall diffusive 
motions of the viruses slightly increased upon LMB treatment of TC7 or HeLa cells, 
as indicated by the MSS slopes, the diffusion constants, the run lengths and the 
speeds (Fig. S2E-J). For example, the relative occurrence of motion periods with an 
MSS-slope larger than 0.5, that is, with a high component of drift, showed a relative 
increase by LMB treatment of about 4-fold in TC7 cells (3.6% versus 15.2%) and 
1.3-fold in HeLa cells (9.2% versus 12.1%) (see Fig. SE and H).  
In the next step, we used a machine learning approach to measure four specific 
features of the virus trajectories, directed motion (DM), fast drift (FD), slow drift (SD), 
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and confined motion (CM) (Fig. 2C). In HeLa cells, DM have speeds of 0.2 to 2 µm/s 
and run lengths of 0.4 up to 7 µm, while FD were slower (0.02 to 0.4 µm/s) and 
shorter (0.05–2.5 µm) (Engelke et al., 2011). Both DM and FD were abolished by 
depolymerization of microtubules with nocodazole, as reported earlier (Engelke et 
al., 2011; Helmuth et al., 2007), and confirmed here (Fig. S2K). In control TC7 cells, 
the viruses spent 0.24% of the trajectory time in DM and 0.34% in FD motion (Fig. 
2D). LMB treatment significantly increased the motility of the virions (see 
Supplementary Movie 1). In particular, LMB increased DM to 1.75%, and reduced 
confined motions to 81.9% compared to 87.3% in the control cells. In addition, LMB 
increased the speed and the run length of individual DM, but not the duration, and 
LMB had little effects on FD, SD or confined motions, as indicated by large scale 
analyses (Fig. 2E, Fig. S3). These results show that in CRM1-inhibited cells 
adenovirus remains engaged with MT-dependent fast transport, which, for example 
can be mediated by the dynein/dynactin motor complex.  
 
A CRM1-dependent gradient of adenovirus motility on microtubules 
close to the nuclear membrane 
To assess if CRM1 inhibition affected the directionality of DMs in TC7 cells, we 
analyzed hundreds of DMs in different subcellular regions. Directionality of DMs in 
the TC7 or HeLa cytoplasm outside the perinuclear area or around the MTOC was 
independent of LMB (Fig. 3A,B, Fig. S3A-C, Fig. S4). DMs towards and away from 
the nucleus were broadly similar in frequency, speed, length and duration (Fig. 3C). 
This makes it unlikely that LMB leads to virion accumulation at the MTOC by 
selective inhibition of the periphery-directed virion motions.  
Similar observations were made in HeLa cells (Fig. S2B, Fig. S2H-J, Fig. S4). These 
cells are known to transport the adenovirus particles less rapidly to the cell nucleus 
than the TC7 cells, and do not enrich the virions at the MTOC upon LMB treatment 
(Strunze et al., 2005; Suomalainen et al., 1999). This is in agreement with the 
observation that LMB increased FDs rather than DMs in HeLa cells (Fig. S5). 
Together, the data suggest that CRM1 or a CRM1 export-cargo does not affect the 
transport directionality of virions, but reduces microtubule-dependent viral motions, 
and may play a role in uncoupling the virions from MT-dependent transport. 
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CRM1 alone and in complex with export cargo is kinetically enriched around the 
nuclear membrane compared to the cytoplasm or the nucleoplasm (Daelemans et 
al., 2005). We found that in control cells, virions were enriched over the nuclear 
periphery bound to NPCs, and depleted in a zone of 3-4 µm around the nuclear 
membrane, as indicated by distance distribution plots of the virus residence time 
(Fig. 4A). In CRM1-inhibited cells, however, only a few virions were observed over 
the nucleus, as expected. Strikingly, LMB treatment enriched virus tracks in the 
close proximity of the nucleus, particularly in the cytoplasmic area 1-3 µm from the 
nuclear rim, as indicated by residence time measurements (Fig. 4A, arrow). Virion 
tracks occurred all over the cytoplasm, and contained the previously detected 
features, DM, FD, SD, and confined motions (Fig. 4B,C). We closely analyzed those 
viral trajectories that contained at least one segment of MT-dependent motions, 
either DM or FD, diagnostic features of microtubule-dependent tracks.  
There was no significant difference in DM or FD between LMB and control cells in 
cytoplasmic regions more than 1.6 µm from the nucleus (Fig. 4C). However, control 
cells exhibited reduced occurrence of DM in close vicinity -1.6 to 1 µm to the nuclear 
rim (Fig. 4D). This gradient of microtubule-dependent motions around the nuclear 
rim was absent in the LMB-treated cells, which showed a quasi uniform DM 
frequency around the nucleus. A similar gradient in control but not LMB-cells was 
detected for nonclassified motions, which comprised shorter and less directional 
motions than DM (Helmuth et al., 2007).  
These findings were supported by the observation that LMB shifted the starting 
points of DM to locations close to the nuclear rim, in most cases closer than 5 µm, 
distinct from control cells where DM were initiated up to 20 µm away from the 
nuclear rim (Fig. 4D). The LMB-treated cells contained virtually no detectable slow 
drifts (SD), in stark contrast to the control cells, which contained high amounts of 
these microtubule-independent motions in the nuclear rim area covering about 1 µm 
each over the nuclear membrane and the adjacent cytoplasm, indicative of virions 
attached to NPCs (Fig. 4C). Analyses in HeLa cells gave similar overall results, 
although the effects of LMB were not as pronounced as in TC7 cells, most likely 
since HeLa cells exhibit less extensive microtubule-dependent motions than TC7 
cells (Fig. S5A-B).  
Collectively, the results reveal that virions engaged infrequently with microtubule-
dependent transport in the immediate proximity of the nucleus unlike in other 
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regions of the cytoplasm. Instead, the nucleus-proximal virions underwent slower 
motions and thereby sustained their drift, and eventually anchored at the NPC, 
indicated by confined motions. Upon CRM1 inhibition, nucleus-proximal virions did 
not uncouple from microtubule-dependent transport near the nuclear rim, but kept 
moving in DM and fast non-classified motions. These virions engaged rarely in 
confined motions, and did not bind to the NPCs, but eventually enriched as 
misdelivered particles at the MTOC.  
 
CRM1 inhibition promotes adenovirus association with microtubules 
proximal to the nucleus 
We next tested if LMB enhanced the location of virions on microtubules near the 
nuclear rim of HER-911 cells. HER-911 cells are known to enrich the incoming 
adenovirus particles at the MTOC upon LMB treatment very much like the TC7 cells 
(Strunze et al., 2005). HER-911 cells have a perinuclear microtubule network, which 
is accessible to analyses by super-resolution fluorescence microscopy. To obtain 
super-resolution, we used the gated-stimulated emission depletion microscopy 
(gSTED) in 3D mode, with spatial resolution of approximately 135 nm in both x-y 
and z dimensions (Fig. 5A). All virions located closer than 1 µm to a microtubule 
were included in the profiling analysis of the perinuclear cytoplasm up to 2.4 µm 
from the nuclear rim. Of note, virions that clustered at the MTOC were not analyzed 
since their density was too high to be resolved by g-STED in 3D mode. For 
reference staining of MTOC with anti-pericentrin antibodies in HER-911 cells and 
frequency analyses of MTOC location with respect to the nuclear rim, see Fig. 
S6A,B and Fig. S1G. This procedure allowed us to score those virions that were 
located in the perinuclear area but not bound to NPCs (data not shown). The 
distance between a virion and the nearest microtubule was determined and plotted 
in relation to the distance from the nuclear rim (Fig. 5B).  
We found that the average distance of the virions from microtubules most proximal 
to the nuclear rim (0 to 0.4 µm) was more than 2-fold reduced in LMB-treated cells 
compared to the control cells. There was no difference in virion location with respect 
to microtubules in the more distal regions of the cell. Similar results were found in 
frequency plots of virion distances from microtubules (Fig. 5C). They demonstrate 
that the nuclear rim zone (≤1 or >1 µm from the nuclear membrane) in LMB-treated 
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cells contained more than twice the fraction of virions closer than about 100 nm from 
a microtubule (red line), compared to control cells (dark blue, p=0.003). This was 
significant (p=0.003). The nuclear rim zone of LMB cells but not control cells also 
contained more virions closer to microtubules than the rest of the cytoplasmic area 
(p values of 0.013 and 0.09, respectively, see Fig. 5C). Similar to the results with 
HER-911 cells, we also found an overall enhancement of virion association with 
microtubules of HeLa cells upon LMB treatment (data not shown). Yet, we could not 
detect any gross changes in the density or the arrangement of microtubules in the 
nucleus-proximal region of 3 µm in HER-911 or HeLa cells (Fig. S6C-E). The results 
show that CRM1 inhibition retains virions on microtubules near the nucleus.  
 
Discussion 
Virus entry into cells requires an extensive array of host proteins, lipids, and solutes. 
Conceptually, information flows from the incoming virus particle to the cell, and 
backwards from the cell to the virion (Wolfrum and Greber, 2013). Here we provide 
novel evidence for information flow from the nucleus to virions moving on 
microtubules proximal to the nucleus. Viruses replicating in the nucleus, such as 
influenza, papilloma, polyoma or human foamy virus are transported towards the 
nucleus within vesicles, and release their genome in the proximity of the nucleus, 
whereas others use bidirectional transport of nucleocapsids on microtubules for the 
nuclear delivery of their genomes through the NPC, such as human immune 
deficiency virus, herpes virus, parvovirus, hepatitis B virus or adenovirus (reviewed 
in Aydin and Schelhaas, 2016; Dodding and Way, 2011; Greber and Way, 2006; 
Hsieh et al., 2010; Trobridge, 2009). The steps required for virus transfer from 
microtubules to the nuclear pores are unknown.  
Our findings reveal three novel aspects of microtubule-dependent transport. First, 
we demonstrate that fast bi-directional virion transport on microtubules is reduced in 
the immediate proximity of the nuclear membrane compared to other regions in the 
cytoplasm. Second, we show that virions in the immediate proximity of the nucleus 
are detached from microtubules. Third, both observations are critically dependent on 
functional nuclear export through the exportin CRM1, as shown by the specific 
CRM1 inhibitor LMB, which binds to CRM1 and precludes CRM1 association with 
NES-bearing cargo and hence Ran-GTP binding (Engelsma et al., 2004; Kudo et al., 
1999; Neville and Rosbash, 1999). We also noted that the LMB treatment increased 
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the fraction of microtubule-dependent motions across the entire cell (Fig. 2D, S3A, 
and Supplementary Movie 1).  
CRM1 was previously shown to be required for the attachment of incoming 
adenovirus particles to NPCs (Strunze et al., 2005). Our data here support a model 
where CRM1 enhances the unloading from or inhibits the loading of virions to 
microtubules. This enables virion access to the NPC for uncoating and nuclear 
delivery of the viral genome, as depicted in Figure 6. We can rule out that the LMB-
inhibited CRM1 competes with virion for docking at the NPC, consistent with the 
notion that the phenylalanine-glycine repeats in the N-terminal domain of Nup214 
are used for adenovirus binding but not for CRM1 interactions (Cassany et al., 2014; 
Fornerod et al., 1997b; Napetschnig et al., 2007).  
Our study uncovers for the first time a gradient of microtubule-dependent motions of 
a cargo in the nucleus-proximal cytoplasm. The motion gradient of adenovirus 
particles extended about 2 µm from the nuclear membrane to the cytoplasm, and 
the gradient was completely abrogated by inhibition of CRM1-dependent nuclear 
export. It is less likely that CRM1 or CRM1/Ran-GTP compete with motors for virion 
binding, since neither recombinant CRM1 nor CRM1/Ran-GTP were found to bind to 
purified adenovirus particles (Greber lab, data not shown).  
The molecular nature of the unloading factor or the factor precluding rebinding of 
adenovirus to the nucleus-proximal microtubules remains unknown. A recent study 
identified a rather large number of proteins in the range of 1000 that are subject to 
CRM1-mediated export from yeast, frog or human cell nuclei (Kirli et al., 2015). One 
possible explanation for the adenovirus motion gradient is that a CRM1 export 
substrate alone or a complex of CRM1/Ran-GTP detaches the motors bound to the 
virion from the microtubules near the nucleus. For example, microtubule binding of 
the kinesin-1 motor could be regulated by nuclear export of histone deacetylases 
(HDAC). Kinesin-1 preferentially binds to and translocates on acetylated and 
detyrosinated microtubules (Reed et al., 2006). In cultured epithelial cells, these 
features occur on microtubules in the perinuclear region, and confer a predominantly 
stable state of microtubules, and a propensity to bend and curve (Friedman et al., 
2010; Piperno et al., 1987; Schulze et al., 1987). HDAC could reduce the 
perinuclear acetylated a-tubulin levels, and thereby lower the interaction of 
microtubules with kinesin-1. Another CRM1 nuclear export substrate modulating 
microtubule-dependent motor movements is the tubulin deglutamylase CCP1 (Kirli 
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et al., 2015; Thakar et al., 2013). Polyglutamylated yeast microtubules enhance the 
run lengths of kinesin-1, and in flagella long polyglutamate side chains enhance 
dynein motility (Kubo et al., 2010; Sirajuddin et al., 2014). Hence, deglutamylation of 
nucleus-proximal microtubules could reduce the transport of cargo, such as 
adenovirus particles.  
Alternatively, a CRM1 export substrate or a complex of CRM1/Ran-GTP/export-
substrate may inhibit the rebinding of virion-motor complexes to microtubules in the 
nuclear vicinity, for example the dynein/dynactin complex. In support of the 
CRM1/Ran-GTP/export-substrate gradient hypothesis, a cytoplasmic Ran-GTP 
gradient of a few micrometers has been measured around condensed 
chromosomes of mitotic cells, and a Ran-GTP gradient of 0.5 to 2 µm around the 
nuclear membrane has been suggested for interphase cells based on mathematical 
modeling (Becskei and Mattaj, 2003; Gorlich et al., 2003; Kalab et al., 2006; Smith 
et al., 2002).  
Our segmentation of virion motions based on machine learning further revealed a 
set of slower microtubule-independent drifting motions in the immediate vicinity of 
the nuclear membrane. These motions were suppressed by LMB. They are distinct 
from random walks, and imply a microtubule-independent transport machinery 
populating the perinuclear ecology. They may be similar to observations with HIV, 
which engages in rapid and directional microtubule-dependent motions, and also 
slower and possibly actin-dependent motions (Arhel et al., 2006; McDonald et al., 
2002). These slow motions may be key for bringing the virions to the NPCs, and 
complement the fast adenovirus motions on microtubules, which are part of the 
perinuclear ecology (Mahamid et al., 2016).  
We speculate that adenovirus particles require a particularly high concentration of 
motors to move on microtubules. The motors bind rather weakly and in low copy 
numbers to the adenovirus particles (Bremner et al., 2009; Gazzola et al., 2009). 
Accordingly, microtubule-dependent adenovirus motion bursts are rare, amounting 
to a few percent of the live time of the virions in the cytosol (Engelke et al., 2011; 
Helmuth et al., 2007). These features may render the virions particularly sensitive to 
spatial cues from the nucleus. This situation may be similar, or distinct for other 
viruses, such as herpes simplex virus, which stably engages with microtubule 
motors and is transported over long distances (Ekstrand et al., 2008; Greber and 
Way, 2006; Radtke et al., 2010). 
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Materials and Methods 
Cells and viruses 
HeLa-K cells (provided by U. Kutay, ETH Zurich, Switzerland), human epithelial KB 
cells (obtained from American Type Culture Collection), adenovirus-transformed 
human embryonic retinoblasts 911 cells (Fallaux et al., 1996) and TC7 cells 
(Suomalainen et al., 1999) were grown at 37°C under 5% CO2 in the growth 
medium, which is Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 
5% FCS and 1% nonessential amino acids (Gibco-BRL). Wild-type HAdV-C2 was 
grown in KB cells, isolated, and subsequently labeled with Atto565, Alexa488 or 
Atto647 (ATTO-TEC GmbH, Siegen, Germany) as published (Greber et al., 1998). 
HAdV-C5_GFP was grown in HER-911 cells complementing the E1 region of 
adenovirus. HAdV-C5_GFP is a non-replicating virus expressing enhanced green 
fluorescent protein (GFP) in the E1 region under the cytomegalovirus (CMV) major 
immediate early promoter (Nagel et al., 2003). Both viruses were purified by 
equilibrium centrifugation over two subsequent CsCl-gradients, and their protein 
concentrations were measured using the Pierce Micro bicinchoninic acid (BCA) 
protein assay reagent kit (Thermo Fisher Scientific, Lausanne, Switzerland) (Greber 
et al., 1993). 
 
Antibodies, plasmids, and chemicals 
Mouse monoclonal anti-β-tubulin antibody (N357) was purchased from Amersham 
(GE Healthcare, UK). Rabbit anti-pericentrin antibody was bought from Abcam 
(Cambridge, UK). Rabbit anti-Rio2 antibody was kindly provided by U. Kutay (ETH, 
Zurich, Switzerland) (Zemp et al., 2009). Goat anti-rabbit or goat anti-mouse IgG 
coupled to Alexa-Fluor-488, 594 or 633 were purchased from Life Technologies 
(Carlsbad, USA). Hemagglutinin (HA)-tagged CRM1 and CRM1-C528S expression 
plasmids were kindly provided by R. Kehlenbach (University of Göttingen, Hilliard et 
al., 2010). For this study, the HA-tags of the CRM1 constructs were replaced by 
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fluorescent protein mCherry using the BamH1 and Xba1 restriction sites. The 
expression construct rPOM121-EGFP3 was obtained from J. Ellenberg (EMBL, 
Heidelberg, Germany). Transient transfections were performed with either JetPEI 
(Polyplus-transfection SA, France) or electroporation using the Neon Transfection 
System (Life Technologies, USA), or BTX T820 Electro Square Porator (BTX 
Instrument Division, Harvard Apparatus, Inc., USA). LMB was purchased from LC 
laboratories (Woburn, USA), and stored in ethanol at -20°C until use.  
 
Virus infection  
Cells were seeded on coverslips in 12 or 24 well dishes and grown to 60-80% 
density for 1-2 days. HER-911 cells were treated with or without 20 nM LMB for 30 
min, pulse infected with fluorescent HAdV-C2 (0.1 µg of virus per well, yielding 
about 50 to 300 internalized viruses per cell) at 37°C for 15 min in growth medium. 
Synchronized infection of HeLa or TC7 cells was performed by binding virus on ice 
for 1 h in the RPMI medium (Sigma-Aldrich) supplemented with 0.2% bovine serum 
albumin (BSA) (Suomalainen et al., 1999). The inoculum was removed, cells 
washed once with pre-warmed growth medium and further incubated at 37°C with or 
without LMB as indicated. Transgene expression from HAdV-C5_GFP was 
measured by continuous incubation of cells with 24ng of virus at 37°C for 16 h in 
growth medium, in presence or absence of LMB.   
 
Immunocytochemistry 
Samples were fixed in 4% paraformaldehyde for 15 min. For staining of 
microtubules, the fixation was performed with PHEMO-fix (3.7% formaldehyde, 
0.05% glutaraldehyde, and 0.5% saponin in PHEMO-buffer, which contains 68mM 
PIPES [pH 6.9], 25mM HEPES, 15mM EGTA, 3mM MgCl2 and 10% DMSO) for 10 
min (Mabit et al., 2002). Samples were quenched with 25 mM ammonium chloride, 
permeabilized with 0.5% Triton X-100 at room temperature, labeled with primary 
antibodies and the fluorophore-conjugated secondary antibodies. The cellular DNA 
was stained with either 4’,6-diamidino-2-phenylindole (DAPI, Molecular Probes, 
Leiden, The Netherlands) or DRAQ5 (Cell Signaling Technology, Inc., 
Massachusetts, USA). The samples were mounted in DAKO medium (Dako 
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Schweiz AG, Baar, Switzerland) for regular confocal microscopy, or in ProLong Gold 
antifade reagent (Life Technologies, Carlsbad, USA) for super-resolution 
microscopy.  
 
Image acquisition and analysis for end-point assays 
Adenovirus infection and nuclear targeting were imaged using Leica SP5 confocal 
laser scanning microscope. HAdV-C5_GFP infection was determined by average 
intensity of the GFP signal over the nuclear area defined by the DAPI stain. To 
quantify the nuclear export, average Rio2 intensities were measured at the nuclear 
area and a 0.8 µm-wide rim region in the cytoplasm adjacent to the nucleus. The 
nuclear export efficiency was defined as the ratio of the average Rio2 intensity at the 
nuclear region divided by the average intensity in the rim region. Nuclear targeting of 
incoming adenovirus was determined by acquisition of image stacks with 0.5 µm z-
step. Maximum projections of each image stack were processed by adaptive local 
thresholding to generate masks for each particle in the virus images and for nuclei in 
DAPI images. The virus masks were used to measure total fluorescence intensities 
over the particle areas (“particle intensity”). The nuclear region was defined by the 
nucleus mask plus an extension by 0.4 µm towards the cytoplasm. The cell 
boundary was determined manually from cytoplasmic autofluorescence in 
computationally overexposed images. The cytoplasmic region was between the 
nuclear rim and the cell boundary. Nuclear targeting efficiency was expressed as 
percentage of total particle intensity in the nuclear area.  
The subcellular location of the MTOC was analyzed in 96-well black plate samples 
(Greiner Bio-One GmbH, Frickenhausen, Germany). Image acquisition was 
performed with an automated ImageXpress Micro XLS wide-field fluorescence 
microscope (Molecular Devices, CA, USA) equipped with a 100x air objective 
(numerical aperture 0.9). The MTOC signal located outside of the DAPI mask was 
identified, and its distance to the nucleus determined. 
To analyze the HAdV localization with respect to microtubules, super-resolution 
images were acquired using Leica TCS SP8 STED 3X super-resolution microscope 
using a 100x immersion objective (oil immersion; numerical aperture 1.4). All STED 
images were acquired in the 3D gSTED mode with a pixel size of 54.8 nm, with an 
effective resolution was estimated to be around 135 nm in both x-y and z 
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dimensions. During the image acquisition, the microscope was focused to the region 
of interest in the virus channel. While the DRAQ5 channel was imaged at the same 
focal plane as the viruses, a z-stack of three images centered at the focal plane was 
acquired in the microtubule channel with 70 nm z-steps. The distances between the 
virions and the nucleus and between the virions and the closest microtubule were 
measured using the single section of the virus and DRAQ5 images, and the 
maximum projection of the MT image stack. The effective resolution here was 
estimated from the average full width at half maximum (FWHM) of the signal from 
single adenovirus particles (n = 236). The procedure was identical as described 
earlier (Wang et al., 2013). 
 
Live imaging and data analyses 
The live acquisition of fluorescent HAdV-C2 in infected cells was conducted by 
spinning disc confocal microscopy, essentially as described earlier (Burckhardt et 
al., 2011). A customized Olympus IX81 inverted microscope (Olympus, Switzerland) 
was equipped with a Yokogawa scanning head QLC100 (VisiTech International, 
UK), triple band-pass excitation (488 nm / 565 nm / 647 nm) and emission filters 
(Chroma, USA), and a temperature-controlled incubation box (Life Imaging 
Services, Basel, Switzerland). The fluorophores were excited by an Innova 70C 
mixed gas laser (Coherent, Germany), and the images recorded through an 
UPlanApo 100x immersion objective (numerical aperture 1.35; Olympus Optical AG, 
Switzerland) on a Cascade 512B EM-CCD camera (Photometrics, USA). 
Image time series were recorded between 30 and 90 min pi. For imaging, infected 
cells were incubated in Hank’s Buffered Salt Solution (Gibco-BRL) supplemented 
with 0.5% BSA and 1 mg/ml ascorbate at pH 7.3. HAdV-C2 labeled with either 
Atto565 or Alexa488 was imaged at a frequency of 25 Hz for 5000 frames. The 
nuclear membrane, which was indicated by DRAQ5 DNA staining in TC7 cells or by 
rPOM121-EGFP3 expression in HeLa cells, was acquired in parallel to virion 
imaging for the same duration but at lower frequency of 0.5 Hz. The videos were 
processed with a single particle tracking program to obtain the 2D trajectories of 
cytoplasmic virions (Sbalzarini and Koumoutsakos, 2005). The accuracy of the virion 
position was estimated to be 20-50 nm according to a signal-to-noise ratio of 2.5 in 
the videos (Sbalzarini and Koumoutsakos, 2005). The trajectories of virus particles 
were processed with a trajectory segmentation algorithm using Support Vector 
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Machines (SVM) as classifiers (Helmuth et al., 2007). The SVM was trained to 
classify segments of trajectories into four categories: microtubule-dependent 
directed motions (DM) and fast drifts (FD), microtubule-independent confined 
motions (CM) and slow drifts (SD), and unclassified stretches of trajectories were 
designated not-classified motions (NC), as described earlier (Burckhardt et al., 
2011; Engelke et al., 2011). Trajectories and segments were analyzed as described 
before (Burckhardt et al., 2011). To detect the outline of the nucleus, images of 
DRAQ5 DNA staining or rPOM121-EGFP3 were thresholded using Otsu’s method to 
generate binary images (Otsu, 1979).  Since the boundaries of binary DRAQ5 and 
rPOM121-EGFP3 images correlated well with each other, both signals were valid 
indicators of the nuclear membrane, which was subsequently employed to 
determine the subcellular localization of virus motions. 
 
Image and data analysis 
All the analyses were conducted on the raw images. Processing, analysis, data 
mining and visualization were performed using CellProfiler (Broad Institute, 
Cambridge, MA, USA) and in-house MATLAB scripts (MathWorks Inc., Natick, MA, 
USA). Deconvolution of the image stacks occurred by AutoQuant (Media 
Cybernetics, Inc., Rockville, MD, USA). The software for single particle tracking and 
trajectory segmentation is available from the website of the Sbalzarini lab 
(http://mosaic.mpi-cbg.de/?q=downloads/toolbox_for_particle_tracking; 
http://mosaic.mpi-cbg.de/?q=downloads/trajectory_segmentation). Source code 
used in this study is available upon request. 
 
 
Acknowledgements 
We thank Ralph Kehlenbach (University of Göttingen, Germany) for the gift of 
CRM1-C528S and discussions, Sten Strunze (University of Zurich) for instrumental 
support at the beginning of the project, Martin Engelke (University of Zurich) for help 
with virus motion analysis and discussion, Urs Ziegler and Jana Döhner (Center for 
Microscopy, University of Zurich) for the help with g-STED microscopy, and Maarit 
Suomalainen for valuable comments to the manuscript and discussions.   
	   19 
 
Competing interests 
The authors declare no competing interests.  
 
Author contributions 
U.F.G. and C.J.B initiated the study. U.F.G., I.-H.W., C.J.B., A.Y. and M.M. designed 
experiments; I.-H.W., C.J.B., A.Y. U.F.G. analyzed experiments; C.J.B., A.Y., I.-
H.W. and M.M. designed and performed life cell imaging experiments; C.J.B and 
A.Y. acquired virus motion data. C.J.B. developed analyses for virus movements, 
including the gradient of viral motions and characterization of virus trajectories; M.M. 
developed routine for nuclear outline detection; C.J.B., I.-H.W. and A.Y. analyzed 
data from life cell imaging experiments; I.-H.W. performed infection and super 
resolution experiments and conducted the analyses; I.-H.W., C.J.B. and U.F.G wrote 
the manuscript. 
 
Funding 
This work was financed by a grant from the Swiss National Science Foundation to 
UFG (310030B_160316), an instrument grant for g-STED super-resolution 
microscopy from the Swiss National Science Foundation to UFG (R’Equip 
316030_145037), and a scholarship from the Taiwanese government (Ministry of 
Education) to I.-H.W. 
 
Data availability 
The image and movie data are available upon request.  
 
 
  
	   20 
References 
 
 Amstutz, B., Gastaldelli, M., Kälin, S., Imelli, N., Boucke, K., Wandeler, E., 
Mercer, J., Hemmi, S. and Greber, U. F. (2008). Subversion of CtBP1 controlled 
macropinocytosis by human Adenovirus serotype 3. EMBO J. 27, 956-966. 
 Arhel, N., Genovesio, A., Kim, K. A., Miko, S., Perret, E., Olivo-Marin, J. 
C., Shorte, S. and Charneau, P. (2006). Quantitative four-dimensional tracking of 
cytoplasmic and nuclear HIV-1 complexes. Nat Methods 3, 817-24. 
 Aydin, I. and Schelhaas, M. (2016). Viral Genome Tethering to Host Cell 
Chromatin: Cause and Consequences. Traffic 17, 327-40. 
 Becskei, A. and Mattaj, I. W. (2003). The strategy for coupling the RanGTP 
gradient to nuclear protein export. Proc Natl Acad Sci U S A 100, 1717-22. 
 Berk, A. J. (2007). Adenoviridae: the viruses and their replication. In Fields 
Virology, vol. 2 (eds D. M. Knipe and P. M. Howley), pp. 2355-2436. Philadelphia, 
PA, USA: Lippincott Williams & Wilkins. 
 Bremner, K. H., Scherer, J., Yi, J., Vershinin, M., Gross, S. P. and Vallee, 
R. B. (2009). Adenovirus transport via direct interaction of cytoplasmic dynein with 
the viral capsid hexon subunit. Cell Host Microbe 6, 523-35. 
 Bruder, J. T. and Kovesdi, I. (1997). Adenovirus Infection Stimulates the 
Raf/Mapk Signaling Pathway and Induces Interleukin-8 Expression. Journal of 
Virology 71, 398-404. 
 Burckhardt, C. J., Suomalainen, M., Schoenenberger, P., Boucke, K., 
Hemmi, S. and Greber, U. F. (2011). Drifting motions of the adenovirus receptor 
CAR and immobile integrins initiate virus uncoating and membrane lytic protein 
exposure. Cell Host Microbe 10, 105-17. 
 Cassany, A., Ragues, J., Guan, T., Begu, D., Wodrich, H., Kann, M., 
Nemerow, G. R. and Gerace, L. (2014). Nuclear import of adenovirus DNA involves 
direct interaction of hexon with an N-terminal domain of the nucleoporin Nup214. J 
Virol. 
 Daelemans, D., Costes, S. V., Lockett, S. and Pavlakis, G. N. (2005). 
Kinetic and molecular analysis of nuclear export factor CRM1 association with its 
cargo in vivo. Mol Cell Biol 25, 728-39. 
 Daigle, N., Beaudouin, J., Hartnell, L., Imreh, G., Hallberg, E., Lippincott-
Schwartz, J. and Ellenberg, J. (2001). Nuclear pore complexes form immobile 
networks and have a very low turnover in live mammalian cells. J Cell Biol 154, 71-
84. 
 Dodding, M. P. and Way, M. (2011). Coupling viruses to dynein and kinesin-
1. The EMBO journal 30, 3527-39. 
 Ekstrand, M. I., Enquist, L. W. and Pomeranz, L. E. (2008). The alpha-
herpesviruses: molecular pathfinders in nervous system circuits. Trends in 
molecular medicine 14, 134-40. 
 Engelke, M. F., Burckhardt, C. J., Morf, M. K. and Greber, U. F. (2011). 
The dynactin complex enhances the speed of microtubule-dependent motions of 
adenovirus both towards and away from the nucleus. Viruses 3, 233-253. 
 Engelsma, D., Bernad, R., Calafat, J. and Fornerod, M. (2004). 
Supraphysiological nuclear export signals bind CRM1 independently of RanGTP 
and arrest at Nup358. Embo J 23, 3643-52. 
 Ewers, H., Smith, A. E., Sbalzarini, I. F., Lilie, H., Koumoutsakos, P. and 
Helenius, A. (2005). Single-particle tracking of murine polyoma virus-like particles 
on live cells and artificial membranes. Proc Natl Acad Sci U S A 102, 15110-5. 
 Fallaux, F. J., Kranenburg, O., Cramer, S. J., Houweling, A., Van 
Ormondt, H., Hoeben, R. C. and Van Der Eb, A. J. (1996). Characterization of 
	   21 
911: a new helper cell line for the titration and propagation of early region 1-deleted 
adenoviral vectors. Hum Gene Ther 7, 215-22. 
 Fornerod, M., Ohno, M., Yoshida, M. and Mattaj, I. W. (1997a). CRM1 is an 
export receptor for leucine-rich nuclear export signals. Cell 90, 1051-60. 
 Fornerod, M., van Deursen, J., van Baal, S., Reynolds, a., Davis, D., 
Murti, K. G., Fransen, J. and Grosveld, G. (1997b). The human homologue of 
yeast CRM1 is in a dynamic subcomplex with CAN/Nup214 and a novel nuclear 
pore component Nup88. The EMBO journal 16, 807-16. 
 Friedman, J. R., Webster, B. M., Mastronarde, D. N., Verhey, K. J. and 
Voeltz, G. K. (2010). ER sliding dynamics and ER-mitochondrial contacts occur on 
acetylated microtubules. J Cell Biol 190, 363-75. 
 Gastaldelli, M., Imelli, N., Boucke, K., Amstutz, B., Meier, O. and Greber, 
U. F. (2008). Infectious adenovirus type 2 transport through early but not late 
endosomes. Traffic 9, 2265-78. 
 Gazzola, M., Burckhardt, C. J., Bayati, B., Engelke, M., Greber, U. F. and 
Koumoutsakos, P. (2009). A stochastic model for microtubule motors describes the 
in vivo cytoplasmic transport of human adenovirus. PLoS Comput Biol 5, e1000623. 
 Giannakakou, P., Nakano, M., Nicolaou, K. C., O'Brate, A., Yu, J., 
Blagosklonny, M. V., Greber, U. F. and Fojo, T. (2002). Enhanced microtubule-
dependent trafficking and p53 nuclear accumulation by suppression of microtubule 
dynamics. Proc Natl Acad Sci U S A 99, 10855-60. 
 Gorlich, D., Seewald, M. J. and Ribbeck, K. (2003). Characterization of 
Ran-driven cargo transport and the RanGTPase system by kinetic measurements 
and computer simulation. Embo J 22, 1088-100. 
 Greber, U. F., Nakano, M. Y. and Suomalainen, M. (1998). Adenovirus 
entry into cells: A quantitative fluorescence microscopy approach. In Adenovirus 
methods and protocols, in Meth. Mol. Med. Vol 21,  (ed. W. S. M. Wold), pp. 217-
230. Totowa, NJ USA: Humana Press, Inc. 
 Greber, U. F., Suomalainen, M., Stidwill, R. P., Boucke, K., Ebersold, M. 
W. and Helenius, A. (1997). The role of the nuclear pore complex in adenovirus 
DNA entry. Embo J 16, 5998-6007. 
 Greber, U. F. and Way, M. (2006). A superhighway to virus infection. Cell 
124, 741-54. 
 Greber, U. F., Willetts, M., Webster, P. and Helenius, A. (1993). Stepwise 
dismantling of adenovirus 2 during entry into cells. Cell 75, 477-86. 
 Gross, S. P. (2004). Hither and yon: a review of bi-directional microtubule-
based transport. Phys Biol 1, R1-11. 
 Helmuth, J. A., Burckhardt, C. J., Koumoutsakos, P., Greber, U. F. and 
Sbalzarini, I. F. (2007). A novel supervised trajectory segmentation algorithm 
identifies distinct types of human adenovirus motion in host cells. J Struct Biol 159, 
347-58. 
 Hilliard, M., Frohnert, C., Spillner, C., Marcone, S., Nath, A., Lampe, T., 
Fitzgerald, D. J. and Kehlenbach, R. H. (2010). The anti-inflammatory 
prostaglandin 15-deoxy-delta(12,14)-PGJ2 inhibits CRM1-dependent nuclear protein 
export. The Journal of biological chemistry 285, 22202-10. 
 Hsieh, M. J., White, P. J. and Pouton, C. W. (2010). Interaction of viruses 
with host cell molecular motors. Curr Opin Biotechnol 21, 633-9. 
 Hutten, S. and Kehlenbach, R. H. (2006). Nup214 is required for CRM1-
dependent nuclear protein export in vivo. Mol Cell Biol 26, 6772-85. 
 Hutten, S. and Kehlenbach, R. H. (2007). CRM1-mediated nuclear export: 
to the pore and beyond. Trends Cell Biol 17, 193-201. 
 Hyman, A. A., Weber, C. A. and Julicher, F. (2014). Liquid-liquid phase 
separation in biology. Annu Rev Cell Dev Biol 30, 39-58. 
	   22 
 Imelli, N., Ruzsics, Z., Puntener, D., Gastaldelli, M. and Greber, U. F. 
(2009). Genetic reconstitution of the human adenovirus type 2 temperature-sensitive 
1 mutant defective in endosomal escape. Virol J 6, 174. 
 Janke, C. (2014). The tubulin code: molecular components, readout 
mechanisms, and functions. J Cell Biol 206, 461-72. 
 Kalab, P., Pralle, A., Isacoff, E. Y., Heald, R. and Weis, K. (2006). Analysis 
of a RanGTP-regulated gradient in mitotic somatic cells. Nature 440, 697-701. 
 Kelkar, S., De, B. P., Gao, G., Wilson, J. M., Crystal, R. G. and Leopold, P. 
L. (2006). A common mechanism for cytoplasmic dynein-dependent microtubule 
binding shared among adeno-associated virus and adenovirus serotypes. J Virol 80, 
7781-5. 
 Kelkar, S. A., Pfister, K. K., Crystal, R. G. and Leopold, P. L. (2004). 
Cytoplasmic dynein mediates adenovirus binding to microtubules. J Virol 78, 10122-
32. 
 Kirli, K., Karaca, S., Dehne, H. J., Samwer, M., Pan, K. T., Lenz, C., 
Urlaub, H. and Gorlich, D. (2015). A deep proteomics perspective on CRM1-
mediated nuclear export and nucleocytoplasmic partitioning. elife 4. 
 Kubo, T., Yanagisawa, H. A., Yagi, T., Hirono, M. and Kamiya, R. (2010). 
Tubulin polyglutamylation regulates axonemal motility by modulating activities of 
inner-arm dyneins. Curr Biol 20, 441-5. 
 Kudo, N., Matsumori, N., Taoka, H., Fujiwara, D., Schreiner, E. P., Wolff, 
B., Yoshida, M. and Horinouchi, S. (1999). Leptomycin B inactivates 
CRM1/exportin 1 by covalent modification at a cysteine residue in the central 
conserved region. Proc Natl Acad Sci U S A 96, 9112-7. 
 Leopold, P. L., Kreitzer, G., Miyazawa, N., Rempel, S., Pfister, K. K., 
Rodriguez-Boulan, E. and Crystal, R. G. (2000). Dynein- and microtubule-
mediated translocation of adenovirus serotype 5 occurs after endosomal lysis. 
Human Gene Therapy 11, 151-65. 
 Li, J., Shariff, A., Wiking, M., Lundberg, E., Rohde, G. K. and Murphy, R. 
F. (2012). Estimating microtubule distributions from 2D immunofluorescence 
microscopy images reveals differences among human cultured cell lines. PLoS ONE 
7, e50292. 
 Lion, T. (2014). Adenovirus infections in immunocompetent and 
immunocompromised patients. Clinical microbiology reviews 27, 441-462. 
 Liu, H., Jin, L., Koh, S. B., Atanasov, I., Schein, S., Wu, L. and Zhou, Z. H. 
(2010). Atomic structure of human adenovirus by cryo-EM reveals interactions 
among protein networks. Science 329, 1038-43. 
 Luisoni, S., Suomalainen, M., Boucke, K., Tanner, L. B., Wenk, M. R., 
Guan, X. L., Grzybek, M., Coskun, U. and Greber, U. F. (2015). Co-option of 
Membrane Wounding Enables Virus Penetration into Cells. Cell Host Microbe 18, 
75-85. 
 Mabit, H., Nakano, M. Y., Prank, U., Saam, B., Dohner, K., Sodeik, B. and 
Greber, U. F. (2002). Intact microtubules support adenovirus and herpes simplex 
virus infections. J Virol 76, 9962-71. 
 Mahamid, J., Pfeffer, S., Schaffer, M., Villa, E., Danev, R., Cuellar, L. K., 
Forster, F., Hyman, A. A., Plitzko, J. M. and Baumeister, W. (2016). Visualizing 
the molecular sociology at the HeLa cell nuclear periphery. Science 351, 969-72. 
 Marsh, M. and Helenius, A. (2006). Virus entry: open sesame. Cell 124, 
729-40. 
 McDonald, D., Vodicka, M. A., Lucero, G., Svitkina, T. M., Borisy, G. G., 
Emerman, M. and Hope, T. J. (2002). Visualization of the intracellular behavior of 
HIV in living cells. J Cell Biol 159, 441-52. 
	   23 
 Meier, O., Boucke, K., Hammer, S. V., Keller, S., Stidwill, R. P., Hemmi, S. 
and Greber, U. F. (2002). Adenovirus triggers macropinocytosis and endosomal 
leakage together with its clathrin-mediated uptake. J Cell Biol 158, 1119-31. 
 Mellman, I. and Warren, G. (2000). The road taken: past and future 
foundations of membrane traffic. Cell 100, 99-112. 
 Moyer, C. L., Wiethoff, C. M., Maier, O., Smith, J. G. and Nemerow, G. R. 
(2011). Functional genetic and biophysical analyses of membrane disruption by 
human adenovirus. J Virol 85, 2631-41. 
 Nagel, H., Maag, S., Tassis, A., Nestle, F. O., Greber, U. F. and Hemmi, S. 
(2003). The alphavbeta5 integrin of hematopoietic and nonhematopoietic cells is a 
transduction receptor of RGD-4C fiber-modified adenoviruses. Gene Ther 10, 1643-
53. 
 Nakano, M. Y., Boucke, K., Suomalainen, M., Stidwill, R. P. and Greber, 
U. F. (2000). The first step of adenovirus type 2 disassembly occurs at the cell 
surface, independently of endocytosis and escape to the cytosol. J Virol 74, 7085-95. 
 Napetschnig, J., Blobel, G. and Hoelz, A. (2007). Crystal structure of the N-
terminal domain of the human protooncogene Nup214/CAN. Proc Natl Acad Sci 
USA 104, 1783-8. 
 Neville, M. and Rosbash, M. (1999). The NES-Crm1p export pathway is not 
a major mRNA export route in Saccharomyces cerevisiae. Embo J 18, 3746-56. 
 Otsu, N. (1979). A threshold selection method from gray-level histograms. 
IEEE Transactions on Systems, Man and Cybernetics 9, 62-66. 
 Piperno, G., LeDizet, M. and Chang, X. J. (1987). Microtubules containing 
acetylated alpha-tubulin in mammalian cells in culture. J Cell Biol 104, 289-302. 
 Puntener, D., Engelke, M. F., Ruzsics, Z., Strunze, S., Wilhelm, C. and 
Greber, U. F. (2011). Stepwise loss of fluorescent core protein V from human 
adenovirus during entry into cells. J Virol 85, 481-96. 
 Radtke, K., Dohner, K. and Sodeik, B. (2006). Viral interactions with the 
cytoskeleton: a hitchhiker's guide to the cell. Cell Microbiol 8, 387-400. 
 Radtke, K., Kieneke, D., Wolfstein, A., Michael, K., Steffen, W., Scholz, T., 
Karger, A. and Sodeik, B. (2010). Plus- and minus-end directed microtubule 
motors bind simultaneously to herpes simplex virus capsids using different inner 
tegument structures. PLoS Pathog 6, e1000991. 
 Reddy, V. S., Natchiar, S. K., Stewart, P. L. and Nemerow, G. R. (2010). 
Crystal structure of human adenovirus at 3.5 A resolution. Science 329, 1071-5. 
 Reed, N. A., Cai, D., Blasius, T. L., Jih, G. T., Meyhofer, E., Gaertig, J. 
and Verhey, K. J. (2006). Microtubule acetylation promotes kinesin-1 binding and 
transport. Curr Biol 16, 2166-72. 
 Robinson, C. M., Singh, G., Lee, J. Y., Dehghan, S., Rajaiya, J., Liu, E. B., 
Yousuf, M. A., Betensky, R. A., Jones, M. S., Dyer, D. W. et al. (2013). Molecular 
evolution of human adenoviruses. Sci Rep 3, 1812. 
 Sbalzarini, I. F. and Koumoutsakos, P. (2005). Feature point tracking and 
trajectory analysis for video imaging in cell biology. J Struct Biol 151, 182-95. 
 Scherer, J. and Vallee, R. B. (2011). Adenovirus recruits dynein by an 
evolutionary novel mechanism involving direct binding to pH-primed hexon. Viruses 
3, 1417-31. 
 Schulze, E., Asai, D. J., Bulinski, J. C. and Kirschner, M. (1987). 
Posttranslational modification and microtubule stability. J Cell Biol 105, 2167-77. 
 Sirajuddin, M., Rice, L. M. and Vale, R. D. (2014). Regulation of microtubule 
motors by tubulin isotypes and post-translational modifications. Nat Cell Biol 16, 
335-44. 
 Smith, A. E., Slepchenko, B. M., Schaff, J. C., Loew, L. M. and Macara, I. 
G. (2002). Systems analysis of Ran transport. Science 295, 488-91. 
	   24 
 Smith, J. G., Cassany, A., Gerace, L., Ralston, R. and Nemerow, G. R. 
(2008). A Neutralizing Antibody Blocks Adenovirus Infection by Arresting 
Microtubule-Dependent Cytoplasmic Transport. J Virol 82, 6492-6500. 
 Staufenbiel, M., Epple, P. and Deppert, W. (1986). Progressive 
reorganization of the host cell cytoskeleton during adenovirus infection. J Virol 60, 
1186-91. 
 Strunze, S., Engelke, M. F., Wang, I. H., Puntener, D., Boucke, K., 
Schleich, S., Way, M., Schoenenberger, P., Burckhardt, C. J. and Greber, U. F. 
(2011). Kinesin-1-mediated capsid disassembly and disruption of the nuclear pore 
complex promote virus infection. Cell Host Microbe 10, 210-23. 
 Strunze, S., Trotman, L. C., Boucke, K. and Greber, U. F. (2005). Nuclear 
targeting of adenovirus type 2 requires CRM1-mediated nuclear export. Mol Biol Cell 
16, 2999-3009. 
 Sun, Q., Carrasco, Y. P., Hu, Y., Guo, X., Mirzaei, H., Macmillan, J. and 
Chook, Y. M. (2013). Nuclear export inhibition through covalent conjugation and 
hydrolysis of Leptomycin B by CRM1. Proc Natl Acad Sci U S A 110, 1303-8. 
 Suomalainen, M., Luisoni, S., Boucke, K., Bianchi, S., Engel, D. A. and 
Greber, U. F. (2013). A direct and versatile assay measuring membrane penetration 
of adenovirus in single cells. J Virol 87, 12367-79. 
 Suomalainen, M., Nakano, M. Y., Boucke, K., Keller, S. and Greber, U. F. 
(2001). Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-
mediated nuclear targeting of virus. Embo J 20, 1310-9. 
 Suomalainen, M., Nakano, M. Y., Keller, S., Boucke, K., Stidwill, R. P. 
and Greber, U. F. (1999). Microtubule-dependent plus- and minus end-directed 
motilities are competing processes for nuclear targeting of adenovirus. J Cell Biol 
144, 657-72. 
 Taylor, M. P., Koyuncu, O. O. and Enquist, L. W. (2011). Subversion of the 
actin cytoskeleton during viral infection. Nature reviews. Microbiology 9, 427-39. 
 Thakar, K., Karaca, S., Port, S. A., Urlaub, H. and Kehlenbach, R. H. 
(2013). Identification of CRM1-dependent Nuclear Export Cargos Using Quantitative 
Mass Spectrometry. Molecular & cellular proteomics : MCP 12, 664-78. 
 Tollefson, A. E., Scaria, A., Hermiston, T. W., Ryerse, J. S., Wold, L. J. 
and Wold, W. S. (1996). The adenovirus death protein (E3-11.6K) is required at 
very late stages of infection for efficient cell lysis and release of adenovirus from 
infected cells. J Virol 70, 2296-306. 
 Trobridge, G. D. (2009). Foamy virus vectors for gene transfer. Expert Opin 
Biol Ther 9, 1427-36. 
 Trotman, L. C., Mosberger, N., Fornerod, M., Stidwill, R. P. and Greber, U. 
F. (2001). Import of adenovirus DNA involves the nuclear pore complex receptor 
CAN/Nup214 and histone H1. Nat Cell Biol 3, 1092-100. 
 Verhey, K. J. and Gaertig, J. (2007). The tubulin code. Cell cycle 6, 2152-60. 
 Verkman, A. S. (2002). Solute and macromolecule diffusion in cellular 
aqueous compartments. Trends Biochem Sci 27, 27-33. 
 Wang, I. H., Suomalainen, M., Andriasyan, V., Kilcher, S., Mercer, J., 
Neef, A., Luedtke, N. W. and Greber, U. F. (2013). Tracking viral genomes in host 
cells at single-molecule resolution. Cell Host Microbe 14, 468-80. 
 Warren, J. C. and Cassimeris, L. (2007). The contributions of microtubule 
stability and dynamic instability to adenovirus nuclear localization efficiency. Cell 
Motil Cytoskeleton 64, 675-89. 
 Warren, J. C., Rutkowski, A. and Cassimeris, L. (2006). Infection with 
replication-deficient adenovirus induces changes in the dynamic instability of host 
cell microtubules. Mol Biol Cell 17, 3557-68. 
 Welte, M. A. (2004). Bidirectional transport along microtubules. Curr Biol 14, 
R525-37. 
	   25 
 Wolfrum, N. and Greber, U. F. (2013). Adenovirus signalling in entry. Cell 
Microbiol 15, 53-62. 
 Xu, D., Marquis, K., Pei, J., Fu, S. C., Cagatay, T., Grishin, N. V. and 
Chook, Y. M. (2015). LocNES: a computational tool for locating classical NESs in 
CRM1 cargo proteins. Bioinformatics 31, 1357-65. 
 Yamauchi, Y. and Greber, U. F. (2016). Principles of Virus Uncoating: Cues 
and the Snooker Ball. Traffic 17, 569-92. 
 Zemp, I., Wild, T., O'Donohue, M. F., Wandrey, F., Widmann, B., Gleizes, 
P. E. and Kutay, U. (2009). Distinct cytoplasmic maturation steps of 40S ribosomal 
subunit precursors require hRio2. J Cell Biol 185, 1167-80. 
 
  
! 26 
Fig1 
 
 
Fig. 1: Functional CRM1 is required for the nuclear targeting and 
genome delivery of adenovirus (related to Fig. S1). 
A) HER-911 cells transfected with CRM1-wt-mCherry or CRM1-C528S-mCherry 
were treated with or without LMB, infected with HAdV-C5_GFP for 16 h, and 
analyzed for endogenous CRM1-substrate Rio2. The expression of CRM1-C528S-
mCherry rescued the nuclear export of Rio2, and HAdV-C5_GFP infection in LMB-
treated cells (A, arrowheads), with only one exception in the representative image 
(arrow). Scale bar = 20 !m. 
B) The mean values of GFP expression of the transfected cells and nuclear export 
indexes were obtained from two independent experiments, including standard 
deviations. 
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C) Representative images of the nuclear targeting of HAdV-C2-Atto647 virions in the 
transfected cells 90 min pi. The expression of CRM1-mCherry wt or C528S shown in 
the white boxed insets, and the position of the nucleus is indicated by the dashed 
line in the blow-up images. Scale bar = 10 µm. 
D) Mean values of the subcellular localization of virions at the nuclear membrane 
and in the cytoplasm, including the standard deviations.  
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Fig2 
 
 
Fig. 2: CRM1 inhibition increases microtubule-dependent motility of 
adenovirus (related to Fig. S2, Fig. S3, Fig. S4). 
A) Virion trajectories (cyan) derived from 5000 time frames at 25 Hz acquisition 
frequency in infected TC7 cells. The position of the nuclear membrane is depicted in 
red, and has been derived from the DRAQ5 nuclear staining (grey). See also Fig. 
S2.    
B) Nuclear targeting of adenovirus in presence or absence of LMB, determined from 
the subcellular localization of virus tracks 30-90 min pi.  
C) Computational segmentation of virion trajectories into directed motion (green), 
fast drift (red), slow drift (orange), not classified (dark blue) or confined motion 
(black). Scale bar: 1 µm.  
D) Analysis of the median time of virion engagement in each motion type, including 
95% confidence intervals obtained by bootstrapping. Color code as in panel C). c 
indicates the number of cells, and t the number of virion trajectories analyzed. Note 
that LMB enhanced the extent of directed motions.  
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E) Detailed characterization of the microtubule-dependent directed motion with 
determination of speed, run length and duration. Note that LMB slightly enhanced 
the speed and run length of DM. The number of cells and DM analyzed are 
indicated.  
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Fig3 
 
 
 
Fig. 3: No apparent bias in the directionality of adenovirus transport in 
the cytoplasm of LMB-treated cells. 
A) Histogram depicting the net displacement of directed motions (DM) towards the 
nucleus (negative values) and away from the nucleus (positive values). N indicates 
the number of DM analyzed in control and LMB-treated TC7 cells.  
B) No apparent preference of directed motions towards or away from the MTOC in 
LMB-treated cells. Green circles indicate the start-point and red circles the end-point 
of a DM which is depicted by a black line.  
C) Detailed characterization of DM towards the MTOC (blue), and away from the 
MTOC (red) in LMB-treated cells, depicting speed, length and duration. N indicates 
the number of DM analyzed.  
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Fig4 
 
 
Fig. 4: CRM1-sensitive motion gradients of adenovirus at the nuclear 
membrane (related to Fig. S5). 
A) Analysis of spatially resolved virion residence time in TC7 cells with or without 
LMB in the time window 30-90 min pi. Note the enhanced location of virions at the 
nuclear membrane in control cells (blue peak at position 0), and at a nucleus-
proximal position in LMB-treated cells (red peak at position at 1-3 µm, black arrow). 
For control cells, we analyzed 70 cells with 3.4 million virus positions, and for LMB-
treatment 41 cells with 8.7 million positions.  
B) Segmentation of virion trajectories reveals directed motion (green), fast drift (red), 
slow drift (orange), confined motions (black) or not classified (dark blue) near the 
nuclear rim. The nuclear rim zone is depicted in gray as a curved area.  
C) Spatially resolved analysis of the median residence time of virion motions shows 
a gradient of directed motions and non-classified motions from -1.6 to 2.4 µm in the 
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perinuclear region. The nuclear rim is located at 0 µm. Each motion step in the 
respective segments was classified according to its localization.  
D) Directed motions shifted from the cell periphery to the perinuclear region by LMB 
treatment, as indicated by frequency plots using the start of the motion as a 
reference point.  
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Fig5 
 
Fig. 5: LMB reduces the distance of adenovirus particles to 
microtubules in immediate surroundings of the nuclear membrane 
(related to Fig. S6). 
A) HER-911 cells were infected with HAdV-C2-Atto565 (red) in presence or absence 
of LMB for 60 or 90 min, fixed, and stained for #-tubulin (green) and nuclei with 
DRAQ5 (blue). gSTED stacks including 3 z-sections were acquired for virus, 
microtubules and the nucleus. The middle sections (z=2) are shown in the raw grey 
scale, and were used to locate virions and the nuclear rim. All three tubulin sections 
were used to locate microtubules to enhance accuracy of virion proximity location. 
Sections 1 and 3 depicting virions and nuclei are shown in artificial grey tone, and 
were not used for analyses. With this procedure, the distance of each virion to the 
closest microtubule (DMT) and the nuclear rim (DN) was determined. An example 
image is shown in the right most panel.  
B) Frequency analysis of virion distance to the nearest microtubule as a function of 
subcellular location. Red bar lines indicate the median value and the interquartile 
range. The bin size of the data is 0.4 !m except for the last bin, which contains all 
virion located 2.4 !m and further away from the nucleus. The green dotted lines 
indicate the distance of 108.8 nm (2 pixels) from the microtubule. Virions located 
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closer then 110 nm were classified as colocalizing with a microtubule. The number 
of cells (c) and virions (v) are indicated for control and LMB-treated cells.  
C) Profiling of the virion distance to the nearest microtubule in the nuclear rim area 
(1 µm each over the nuclear membrane and the adjacent cytoplasm) and in the 
more distant cytoplasm (cyto) show that LMB enhances the fraction of virions 
located at less than 100 nm distant from the nearest microtubule. Statistical 
analyses and p-values for the DMT distribution were obtained from the Kolmogorow-
Smirnov test. 
  
	   35 
Fig6 
 
 
Fig. 6: Model for CRM1-regulated adenovirus association with MT-
dependent transport 
Incoming adenovirus particles are transported on microtubules towards the nucleus 
by the dynein/dynactin motor complex, and an unidentified plus end directed motor, 
such as kinesin (Bremner et al., 2009; Suomalainen et al., 1999). The study here 
identified a motion gradient of adenovirus in the immediate cytoplasmic vicinity of 
the nucleus about 1 µm from the nuclear membrane. In this zone, the microtubule-
dependent virion motility was strongly reduced, and the virion distance to the 
nearest microtubule strongly increased. These motility and location gradients were 
disrupted in cells treated with the nuclear export inhibitor LMB. The data argue for 
the existence of one or several spatial cues, which uncouple the incoming virions 
from microtubules in the immediate proximity of the nuclear membrane, and enable 
virion docking to the nuclear pore complex. At the NPC, the virion disassembles by 
a cue from activated kinesin-1, which displaces capsid fragments to the distal 
cytoplasm, and allows viral DNA import into the nucleus (Strunze et al., 2011; 
Trotman et al., 2001).  
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The nuclear export factor CRM1 controls juxta-nuclear microtubule-
dependent virus transport 
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Fig. S1: Rescue of adenovirus nuclear targeting and genome delivery 
in LMB-treated HeLa and HER-911 cells expressing LMB-resistant 
CRM1 (related to Fig. 1).  
A) HeLa cells were transfected with CRM1-wt-mCherry or CRM1-C528S-
mCherry and treated with or without LMB, followed by inoculation of HAdV-
C5_GFP for 16 h. Scale bar = 20 µm. 
B) Quantification of the average GFP intensity, and the infection index for the 
transfected cells. Mean values and standard deviations were obtained from two 
independent experiments. 
C) Examination of the nuclear targeting of incoming HAdV-C2-Atto647 particles 
in CRM1-wt-mCherry and CRM1-C528S-mCherry expressing HeLa cells 90 min 
pi. The transfected cells are displayed in the inset with white outline. The dashed 
lines in the blown-up images in the right row indicate the nuclear region. Scale 
bar = 20 µm. 
D) Quantification of HAdV-C2-Atto647 nuclear targeting. Mean values of the 
subcellular localization of the virions at the nuclear membrane and in the 
cytoplasm, including the standard deviations.  
E) Representative data sets of HAdV-C5_GFP infections. The notched boxplots 
show the 25th to 75th percentile and median of data points. Outliers, which are 1.5 
times the interquartile range (indicated by the whisker) away from the edge of the 
box, are represented by the plus signs. 
F) Assessment of nuclear export of endogenous Rio2 in HER-911 cells 
transfected with CRM1-wt-mCherry or CRM1-C528S-mCherry, in presence or 
absence of LMB.  
G) Representative image of incoming HAdV-C2-Atto565 particles arrested at 
MTOC upon LMB treatment in HER-911 cell 90 min pi. The MTOC was 
immunolabeled by an anti-pericentrin antibody. The dashed line indicates the 
outline of the cell. Scale bar = 20 µm. 
! S4 
FigS2 
Fig. S2: Analyzing the subcellular localization of viruses by live cell 
imaging in HeLa and TC7 cells (related to Fig. 2). 
A) To validate the delineation of the nuclear rim determined by DRAQ5 in fixed 
specimens, TC7 cells were transfected with rPOM121-EGFP3, and stained with 
DRAQ5 in live mode. The boundaries of the rPOM121-EGFP3 and DRAQ5 
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signals were determined and compared with each other using the same 
procedures as for the fixed cells. The results show a high degree of overlap 
between the POM121 and the DRAQ5 nuclear rims.  
B) Analyses of HAdV-C2-Alexa565 located at the nuclear membrane in HeLa 
cells upon treatment with LMB or nocodazole (Noc) 30-90 min pi.  
C) Residence time of HAdV-C2-Alexa565 in relation to the distance of the virions 
from the nuclear membrane in the time windows 0-30 min and 30-90 min pi.  
D) Distance plot of residence time of HAdV-C2-Alexa565 in presence or absence 
of LMB, 30-90 min pi.  
E, F) Characterization of adenovirus movements in infected TC7 and HeLa cells 
by frequency plots of mss slopes and diffusion constants of virion trajectories, 
and histogram profiling in control cells (blue) and LMB-treated cells (red). Events 
with mss slopes >0.5 represent active transport, 0.5 random walk (dashed line), 
and <0.5 restricted diffusion. The number of cells (c) and virus tracks (t) analyzed 
are indicated for each panel.  
G, H) Frequency plots of trajectory run lengths and overall displacements of 
virions. Note the indication of the relative occurrence of motion periods with an 
MSS-slope larger than 0.5, that is, with a high component of linear motion 
(panels E and H). 
I, J) Frequency plots of speed and duration of virion movements.  
K) Abolishment of adenovirus directed motions and fast drifts in HeLa cells by 
nocodazole. Representation of the median time, for which virions engaged in 
directed motion (DM, green), fast drift (FD, red), slow drift (SD, orange), diffusion 
(cyan), confined motions (CM, black) and not classified (NC, dark blue) including 
95% confidence intervals (horizontal bars) obtained by bootstrapping. Results are 
expressed as a fraction of total time analyzed for each condition, and include the 
number of cells (c), and the number of virus trajectories (t).  
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FigS3 
 
Fig. S3:  Features of virion motions in TC7 cells (related to Fig. 2). 
The virion trajectories from control and LMB-treated cells were segmented and 
categorized into directed motion (A-D), fast drift (E-H), slow drift (I-L), and 
confined motion (M-P). Each motion type was analyzed for its mss slope (A, E, I, 
M), run length (B, F, J, N), duration (C, G, K, O) and directionality (D, H, L, P). 
The distribution of these parameters was plotted and compared between control 
(blue) and LMB-treated cells (red), including the number of segments analyzed 
(s). 
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FigS4 
 
Fig. S4: Features of virion motions in HeLa cells (related to Fig. 2). 
The virion trajectories from control and LMB-treated cells were segmented and 
categorized into directed motion (A-D), fast drift (E-H), slow drift (I-L), and 
confined motion (M-P). Each motion type was analyzed for its mss slope (A, E, I, 
M), run length (B, F, J, N), duration (C, G, K, O) and directionality (D, H, L, P). 
The distribution of these parameters was plotted and compared between control 
(blue) and LMB-treated cells (red), including the number of segments analyzed 
(s). 
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FigS5 
 
Fig. S5: CRM1-sensitive motion gradient of adenovirus in HeLa cells 
(related to Fig. 4). 
A) Virion motions in relation to their distance from the nucleus in the zone -1.6 
µm to 2.8 µm around the nuclear rim. The nuclear rim is positioned at 0. Negative 
distance values indicate overlap with the nuclear mask, and positive values 
indicate motions in the cytoplasm distant from the nucleus. Events were binned 
into 0.4 µm segments, and results plotted as the median time of virions in each 
motion type. Results from control cells are represented in black, and LMB-treated 
cells in grey squares.  
B) Subcellular localization of the starting points of the DM and FD across the 
entire cytoplasm of control and LMB-treated cells.  
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FigS6 
 
Fig. S6: Distance profiling of the location of the MTOC with respect to 
the nuclear membrane and microtubule morphology in the 
perinuclear zone (related to Fig. 5). 
A) A representative image of the microtubule organizing centers (MTOCs) 
stained with an anti-pericentrin antibody (green), and DAPI-stained nuclei (blue) 
as a reference in HER-911 cells. The distance between the MTOC and the 
nuclear rim (white line) is indicated by a red line and a corresponding red number 
in µm. Scale bar: 20 µm.  
B) Histogram showing the frequency of MTOC location with respect to the 
nuclear rim.  
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C) Morphology of the microtubule network in HER-911 and HeLa cells. Control or 
LMB-treated cells were stained for β-tubulin, imaged by confocal fluorescence 
microscopy, and displayed as maximal projections of deconvolved image stacks. 
Scale bar = 10 µm.  
D, E) Three z-sections of microtubule-stained HER-911 (B) and HeLa (C) cells 
were acquired at the middle of the cells in 3D-gSTED mode of the confocal laser 
scanning microscope. The maximum projections were created from image 
stacks. Scale bar = 5 µm. 
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MovieS1 
Supplementary Movie 1: Motility of adenovirus particles in control 
and LMB-treated TC7 cells.  
Control or LMB-treated TC7 cells stained for DNA with DRAQ5 were warmed for 
30-90 min from cold-synchronized inoculation of HAdV-C2-Alexa488 (white), and 
imaged by spinning disc confocal microscopy at a frequency of 25 Hz. For details 
about the procedure, see main text.  
 
